3656 results for «208»

Filter By

3656 results

The digital pulse: innovation in the cathlab

20 May 2026 – From EuroPCR 2026

This session highlights transformative innovations in the catheterization laboratory that prioritize patient-centered care and enhanced safety. Focus areas include advancements in radiation practice through new technology and the integration of artificial intelligence to improve image analysis, decision-making, and procedural efficiency in interventional cardiology.

Complex transfemoral TAVI: how to manage the root to success

20 May 2026 – From EuroPCR 2026

Addressing the challenges of complex transfemoral TAVI, this session provides expert guidance on managing difficult vascular access routes to ensure procedural success. Topics include advanced techniques for straightening pathways, managing hostile access, and innovative strategies for contrast-zero TAVI in challenging anatomies.

INOCA/ANOCA: technical aspects

20 May 2026 – From EuroPCR 2026

This session covers technical aspects critical to the evaluation and management of ischemia with non-obstructive coronary arteries (INOCA) and angina with non-obstructive coronary arteries (ANOCA). Key topics include the impact of guide catheter shape, injection techniques for thermodilution measurements, advanced perfusion CMR diagnostics, and the physiological...

Stentless PCI, DCB and BVS in complex scenarios

20 May 2026 – From EuroPCR 2026

This session explores the use of stentless percutaneous coronary interventions (PCI) employing drug-coated balloons (DCB) and bioresorbable scaffolds (BVS) in complex coronary scenarios. Through detailed case discussions, it addresses decision-making processes, technical considerations, and practical tips for successfully completing PCI without permanent stenting.

DCB - Going beyond in-stent restenosis

20 May 2026 – From EuroPCR 2026

This session examines the expanding role of drug-coated balloons (DCB) beyond in-stent restenosis, including treatment of acute coronary syndromes, calcified lesions, and bifurcations. It reviews current evidence supporting DCB-based revascularization and outlines essential procedural steps to optimize outcomes.

New tools for risk stratification in STEMI

20 May 2026 – From EuroPCR 2026

This session highlights novel tools and scores for risk stratification in ST-elevation myocardial infarction (STEMI) patients. It covers prognostic indices such as the index of microcirculatory resistance, the PREDICT-STEMI score, thrombus characteristics, sex differences in outcomes, renal impairment impacts, and benefits of complete revascularization strategies.

Complications in coronary interventions

20 May 2026 – From EuroPCR 2026

This session reviews uncommon and challenging complications encountered during coronary interventions. Cases include brachial arteriovenous fistula following radial access, retained guidewires, coronary sinus perforation during device implantation, and complex atherectomy procedures, emphasizing preparedness and management strategies.

Reliability and application of angio-based physiology in daily work

20 May 2026 – From EuroPCR 2026

This session evaluates the reliability and clinical application of angiography-based physiological assessments in daily practice. Topics include comparisons of angiography-derived microvascular resistance and flow metrics with invasive methods, reproducibility of quantitative flow ratio (QFR), and its correlation with symptom burden and other imaging modalities.

ECLS-SHOCK: venoarterial membrane oxygenation in cardiogenic shock

27 Aug 2023

Panos Xaplanteris & Leonidas Koliastasis provide their take on the final results of the ECLS-SHOCK (Extracorporeal Life Support in Infarct-Related Cardiogenic Shock) which were presented by Holger Thiele during the ESC 2023 congress in Amsterdam.

Panagiotis Xaplanteris

Author

Panagiotis Xaplanteris

Author

Leonidas Koliastasis
ECLS-SHOCK

Complicated subendothelial dissection during left anterior descending coronary artery – first diagonal branch bifurcation treatment with Culotte technique

06 Jan 2025

Learn more about troubleshooting and tailor-made treatment combining 2D and 3D OCT thanks to this image in cardiology!

Troubleshooting of a complicated subendothelial dissection using 2D and 3D OCT

Redo-surgery versus transcatheter valve-in-valve for mitral bioprosthetic dysfunction: The SURVIV trial

03 Apr 2026

Yohei Ohno provides his takeaways from the results of the SURVIV trial, which were presented by Dimytri Siqueira during the ACC.26 in New Orleans.

Yohei Ohno

Author

Yohei Ohno
Redo-surgery versus transcatheter valve-in-valve for mitral bioprosthetic dysfunction: The SURVIV trial

Jupiter Endovascular announces positive results from SPIRARE I first-in-human study presented at TCT 2025

26 Oct 2025

Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial

27 Oct 2025

Aaysha Cader provides her take on the Short-CUT trial presented by Suzanne J. Baron at TCT 2025, in San Francisco.

Author

Aaysha Cader
Randomised comparison of intravascular lithotripsy vs. cutting balloon treatment in calcified coronary artery disease – The Short-CUT trial

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF

Five-year clinical and echocardiographic outcomes from the PARTNER 3 Low-Risk randomized trial

26 Oct 2023

Alex Sticchi provides his take on the 5-year outcomes from PARTNER 3 Low Risk which were presented by Martin B. Leon at TCT Congress 2023.

Alessandro Sticchi

Author

Alessandro Sticchi
Five-Year Clinical and Echocardiographic Outcomes from The PARTNER 3 Low-Risk Randomized Trial

ILUMIEN IV: OPTIMAL PCI - Optical Coherence Tomography Guided Coronary Stent Implantation Compared with Angiography: A Multicenter Randomized Trial in Percutaneous Coronary Intervention

29 Aug 2023

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Claudio Laudani

Author

Claudio Laudani
Daniele Giacoppo

Author

Daniele Giacoppo
ILUMIEN IV: OCT versus angiography
Didn’t find what you were looking for?